CHINA GEWANG BIOTECHNOLOGY, INC. - Statements of Operations - USD ($)	3 Months Ended		6 Months Ended
	May. 31, 2015	May. 31, 2014	May. 31, 2015	May. 31, 2014
Income Statement
REVENUE	$ 1,045,750	$ 578,711	$ 2,006,612	$ 1,026,895
Cost of goods sold	(284,699)	(179,451)	(547,058)	(330,278)
Gross profit	761,051	399,260	1,459,554	696,617
OPERATING EXPENSES:
Selling and marketing	174,677	106,235	328,645	219,548
General and administrative	131,231	27,220	188,253	53,693
TOTAL OPERATING EXPENSES	305,907	133,455	516,898	273,241
Operating income	455,144	265,805	942,656	423,376
Other income:
Interest income	1,431	2,027	3,871	3,779
Income before provision for income taxes	456,575	267,832	946,527	427,155
Provision for income taxes	114,623	66,958	237,610	106,789
Net income before noncontrolling interests	341,952	200,874	708,917	320,366
Noncontrolling interest	(15,474)		(32,077)
Net income attributable to common stockholders	$ 326,478	$ 200,874	$ 676,840	$ 320,366
Earnings per common share	$ 0.01	$ 0.01	$ 0.02	$ 0.01
Weighted average shares outstanding	37,456,522	35,500,000	36,489,011	35,500,000
Comprehensive income:
Net income before noncontrolling interests	$ 341,952	$ 200,874	$ 708,917	$ 320,366
Foreign currency translation adjustment	25,735	(18,709)	5,558	(17,581)
Comprehensive income	367,687	182,165	714,475	302,785
Comprehensive income attributable to noncontrolling interests	(16,760)		(32,355)
Net comprehensive income attributable to common stockholders	$ 350,927	$ 182,165	$ 682,120	$ 302,785